Currently, this novel agent is in limited supply outside of clinical trials . Securing it requires participation in a specific research program , which is typically conducted at select medical facilities . https://glp-3-retatrutide-for-sa179673.aboutyoublog.com/54829225/accessing-the-medication-availability-how-to-get-a-glp-3-agonist-treatment